Skip to content

Kidney disease ends here.

example-header

The Covid-19 vaccines and kidney disease

Photo by Hakan Nural on Unsplash

The Covid-19 vaccines and kidney disease

We've been working with the professional kidney organisations and charities to ensure we all provide consistent, accurate information about the Covid-19 vaccines and work together to drive change for people affected by kidney disease.

Things change quickly, so we’ll try and keep the information as up-to-date as we can.

About the vaccine

  • Millions of people in the UK have received one of the Covid-19 vaccines. They are all suitable for adults with kidney disease.
  • There are several types of vaccine. Find out more about them and how they work in the frequently asked questions below.
  • You should have the vaccine when you are offered it. People with advanced kidney disease are much more likely to develop severe illness and even pass away from Covid-19. The vaccine will offer protection for you and your community.
  • If you are over 16 and have had a transplant, or are on dialysis, you should be invited to have your vaccination soon, if you haven’t already.
hands space face

Keep following the advice

Remember that even if you receive the vaccine you should still;

  • follow social distancing guidance
  • wash your hands regularly
  • wear a face mask.

It will take a few weeks before your immunity builds up and we don’t yet know whether people who are vaccinated can still pass the virus on. The infection level is currently high so following this advice will reduce the risk to you and your friends and family.

Your questions answered

You may have questions about the Covid-19 vaccines and how they affect you.
Here are some of the most common questions with answers from kidney specialists.

If you have any other concerns, do address these with your doctors. 

The need for research

We're helping to fund an urgent clinical trial testing if a drug used for tapeworm can protect high-risk kidney patients from Covid-19. If successful, the trial may pave the way for a new treatment to prevent or alleviate the impact of Covid-19 in people on dialysis, those who have had a kidney transplant, and people with auto-immune diseases affecting the kidneys.

Research in the lab
Helen Rogerson
Scroll To Top